乳腺癌抗雌激素耐药蛋白1抗体

参考价:¥1580
供货周期: 现货
品牌: LMAI Bio
规格: 50ul/100ul/200ul
货号: LM6223R
CAS号:
上海联迈生物工程有限公司
银牌会员6年生产商
关注展位 全部试剂
产品详情

1.png

乳腺癌抗雌激素耐药蛋白1抗体

 

英文名称    BCAR1    

中文名称    乳腺癌抗雌激素耐药蛋白1    

别    名    Breast cancer anti estrogen resistance 1 protein; BCAR 1; Bcar1; BCAR1_HUMAN; Breast cancer anti estrogen resistance 1; Breast cancer anti-estrogen resistance protein 1; CAS; Cas scaffolding protein family member 1; Crk associated substrate; Crk associated substrate p130Cas; CRK-associated substrate; CRKAS; P130CAS.      

研究领域    肿瘤  信号转导  激酶和磷酸酶      

抗体来源    Rabbit    

克隆类型    Polyclonal    

交叉反应    Human, Mouse, Rat, Dog, Cow, Rabbit,     

产品应用    ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 (石蜡切片需做抗原修复) 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.    

分 子 量    93kDa    

细胞定位    细胞浆 细胞膜     

性    状    Lyophilized or Liquid    

浓    度    1mg/ml    

免 疫 原    KLH conjugated synthetic peptide derived from human BCAR1:561-660/870     

亚    型    IgG    

纯化方法    affinity purified by Protein A    

储 存 液    0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.    

保存条件    Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.    

PubMed    PubMed    

产品介绍    p130 represents one of several known substrates for v-Crk encoded p47. p130 Cas (for Crk-associated substrate) exhibits a high level of tyrosine phosphorylation and is tightly associated with v-Crk, suggesting a role in v-Crk-mediated cell signaling. The molecular cloning of p130 Cas has shown it to represent a novel SH3 containing signaling molecule with a cluster of multiple putative SH2-binding motifs for v-Crk. By immunoprecipitation analysis, p130 Cas has been shown to be highly phosphorylated at tyrosine residues subsequent to either v-Src p60 or v-Crk-mediated transformation and to form stable complexes with both of these transforming proteins. p130 Cas behaves as an extremely potent substrate for protein tyrosine kinases and has been reported to relocate from the cytoplasm to cell membrane upon tyrosine phosphorylation. One proposed model is that the SH2 domain of v-Crk functions to activate c-Src kinase, which in turn phosphorylates p130 Cas.    


乳腺癌抗雌激素耐药蛋白1抗体信息由上海联迈生物工程有限公司为您提供,如您想了解更多关于乳腺癌抗雌激素耐药蛋白1抗体报价、型号、参数等信息, 欢迎来电或留言咨询。除供应乳腺癌抗雌激素耐药蛋白1抗体外,上海联迈生物工程有限公司还可为您提供三羧酸载体蛋白SFXN1抗体、丝氨酸/苏氨酸SFRS8抗体等产品, 公司有专业的客户服务团队,是您值得信赖的合作伙伴。

相关试剂 更多

相关产品

当前位置: 仪器信息网 LMAI-BIO 试剂 乳腺癌抗雌激素耐药蛋白1抗体

关注

拨打电话

留言咨询